Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$1.58 - $4.77 $1.43 Million - $4.32 Million
-905,405 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$3.74 - $6.28 $134,434 - $225,734
35,945 Added 4.13%
905,405 $3.98 Million
Q1 2020

May 12, 2020

BUY
$2.33 - $12.98 $1.16 Million - $6.46 Million
497,353 Added 133.66%
869,460 $3.41 Million
Q4 2019

Feb 12, 2020

BUY
$6.75 - $11.15 $64,084 - $105,858
9,494 Added 2.62%
372,107 $3.98 Million
Q3 2019

Nov 12, 2019

BUY
$8.57 - $10.72 $174,210 - $217,916
20,328 Added 5.94%
362,613 $3.12 Million
Q2 2019

Aug 09, 2019

BUY
$7.58 - $10.0 $2.59 Million - $3.42 Million
342,285 New
342,285 $2.81 Million
Q4 2017

Feb 12, 2018

SELL
$20.9 - $49.36 $9.54 Million - $22.5 Million
-456,282 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$39.62 - $46.17 $18.1 Million - $21.1 Million
456,282
456,282 $19.4 Million

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $95.8M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.